SARs at the monoamine transporters for a novel series of modafinil analogues

ACS Medicinal Chemistry Letters

Volumn 2, Issue 1, 2011, Pages 48-52

  Cao, Jianjing ^a   Prisinzano, Thomas E ^b   Okunola, Oluyomi M ^a   Kopajtic, Theresa ^a   Shook, Matthew ^a   Katz, Jonathan L ^a   Newman, Amy Hauck ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

modafinil analogues; monoamine transporters; SAR

Indexed keywords

MODAFINIL; VESICULAR MONOAMINE TRANSPORTER;

ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG SYNTHESIS; ENANTIOMER; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

MUS;

EID: 78651469586     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml1002025     Document Type: Article

References (30)

1. Ballon, J. S.; Feifel, D. A systematic review of modafinil: Potential clinical uses and mechanisms of action J. Clin. Psychiatry 2006, 67, 554-566
2. Minzenberg, M. J.; Carter, C. S. Modafinil: A review of neurochemical actions and effects on cognition Neuropsychopharmacology 2008, 33, 1477-1502
3. Dackis, C. A.; Kampman, K. M.; Lynch, K. G.; Pettinati, H. M.; O'Brien, C. P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence Neuropsychopharmacology 2005, 30, 205-211
4. Martinez-Raga, J.; Knecht, C.; Cepeda, S. Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies Curr. Drug Abuse Rev. 2008, 1, 213-221
5. Shearer, J.; Darke, S.; Rodgers, C.; Slade, T.; van Beek, I.; Lewis, J.; Brady, D.; McKetin, R.; Mattick, R. P.; Wodak, A. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence Addiction 2009, 104, 224-233
6. Turner, D. C.; Robbins, T. W.; Clark, L.; Aron, A. R.; Dowson, J.; Sahakian, B. J. Cognitive enhancing effects of modafinil in healthy volunteers Psychopharmacology 2003, 165, 260-269
7. Rasetti, R.; Mattay, V. S.; Stankevich, B.; Skjei, K.; Blasi, G.; Sambataro, F.; Arrillaga-Romany, I. C.; Goldberg, T. E.; Callicott, J. H.; Apud, J. A.; Weinberger, D. R. Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition Neuropsychopharmacology 2010, 35, 2101-2109
8. Ferraro, L.; Antonelli, T.; Tanganelli, S.; O'Connor, W. T.; Perez de la Mora, M.; Mendez-Franco, J.; Rambert, F. A.; Fuxe, K. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade Neuropsychopharmacology 1999, 20, 346-356
9. Madras, B. K.; Xie, Z.; Lin, Z.; Jassen, A.; Panas, H.; Lynch, L.; Johnson, R.; Livni, E.; Spencer, T. J.; Bonab, A. A.; Miller, G. M.; Fischman, A. J. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro J. Pharmacol. Exp. Ther. 2006, 319, 561-569
10. Mignot, E.; Nishino, S.; Guilleminault, C.; Dement, W. C. Modafinil binds to the dopamine uptake carrier site with low affinity Sleep 1994, 17, 436-437
11. Zolkowska, D.; Jain, R.; Rothman, R. B.; Partilla, J. S.; Roth, B. L.; Setola, V.; Prisinzano, T. E.; Baumann, M. H. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil J. Pharmacol. Exp. Ther. 2009, 329, 738-746
12. Volkow, N. D.; Fowler, J. S.; Logan, J.; Alexoff, D.; Zhu, W.; Telang, F.; Wang, G. J.; Jayne, M.; Hooker, J. M.; Wong, C.; Hubbard, B.; Carter, P.; Warner, D.; King, P.; Shea, C.; Xu, Y.; Muench, L.; Apelskog-Torres, K. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications J. Am. Med. Assoc. 2009, 301, 1148-1154
13. Andersen, M. L.; Kessler, E.; Murnane, K. S.; McClung, J. C.; Tufik, S.; Howell, L. L. Dopamine transporter-related effects of modafinil in rhesus monkeys Psychopharmacology 2010, 210, 439-448
14. Dopheide, M. M.; Morgan, R. E.; Rodvelt, K. R.; Schachtman, T. R.; Miller, D. K. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants Eur. J. Pharmacol. 2007, 568, 112-123
15. Gold, L. H.; Balster, R. L. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil Psychopharmacology 1996, 126, 286-292
16. Reichel, C. M.; See, R. E. Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse Psychopharmacology 2010, 210, 337-346
17. Jasinski, D. R. An evaluation of the abuse potential of modafinil using methylphenidate as a reference J. Psychopharmacol. 2000, 14, 53-60
18. Vosburg, S. K.; Hart, C. L.; Haney, M.; Rubin, E.; Foltin, R. W. Modafinil does not serve as a reinforcer in cocaine abusers Drug Alcohol Depend. 2010, 106, 233-236
19. Donovan, J. L.; Malcolm, R. J.; Markowitz, J. S.; DeVane, C. L. Chiral analysis of d-and l-modafinil in human serum: Application to human pharmacokinetic studies Ther. Drug Monit. 2003, 25, 197-202
20. Dinges, D. F.; Arora, S.; Darwish, M.; Niebler, G. E. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss Curr. Med. Res. Opin. 2006, 22, 159-167
21. Robertson, P., Jr.; Hellriegel, E. T. Clinical pharmacokinetic profile of modafinil Clin. Pharmacokinet. 2003, 42, 123-137
22. Garnock-Jones, K. P.; Dhillon, S.; Scott, L. J. Armodafinil CNS Drugs 2009, 23, 793-803
23. Newman, A. H.; Allen, A. C.; Izenwasser, S.; Katz, J. L. Novel 3 alpha-(diphenylmethoxy)tropane analogs: Potent dopamine uptake inhibitors without cocaine-like behavioral profiles J. Med. Chem. 1994, 37, 2258-2261
24. De Risi, C.; Ferraro, L.; Pollini, G. P.; Tanganelli, S.; Valente, F.; Veronese, A. C. Efficient synthesis and biological evaluation of two modafinil analogues Bioorg. Med. Chem. 2008, 16, 9904-9910
25. Lafon, L. Benzylsulfinylacetamide derivatives and their therapeutic use. European Patent 0097071A1, 1983.
26. Prisinzano, T.; Podobinski, J.; Tidgewell, K.; Luo, M.; Swenson, D. Synthesis and determination of the absolute configuration of the enantiomers of modafinil Tetrahedron: Asymmetry 2004, 15, 1053-1058 (Pubitemid 38352850)
27. Zou, M. F.; Cao, J.; Kopajtic, T.; Desai, R. I.; Katz, J. L.; Newman, A. H. Structure-activity relationship studies on a novel series of (S)-2β-substituted 3alpha-[bis(4-fluoro-or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation J. Med. Chem. 2006, 49, 6391-6399
28. Kulkarni, S. S.; Grundt, P.; Kopajtic, T.; Katz, J. L.; Newman, A. H. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: Comparative molecular field analysis, synthesis, and pharmacological evaluation J. Med. Chem. 2004, 47, 3388-3398
29. Newman, A. H.; Kline, R. H.; Allen, A. C.; Izenwasser, S.; George, C.; Katz, J. L. Novel 4′-substituted and 4′,4′′- disubstituted 3 α-(diphenylmethoxy)tropane analogs as potent and selective dopamine uptake inhibitors J. Med. Chem. 1995, 38, 3933-3940
30. Katz, J. L.; Izenwasser, S.; Kline, R. H.; Allen, A. C.; Newman, A. H. Novel 3α-diphenyl-methoxy-tropane analogs: Selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine J. Pharmacol. Exp. Ther. 1999, 288, 302-315